Work

Economic modeling of the combined effects of HIV disease, heart disease and lipoatrophy based on ACTG 5142 trial data

Year: 2008

Type: conference-abstract

Abstract: Purpose of the studyAntiretroviral (ARV) regimens may be statistically noninferior in clinical trials, but have very different economic outcomes due to differences in costs and adverse event profiles.Given the heavy cost burden of HIV disease, it is important to consider economic issues when selecting an ARV regimen.This study examines the cost and consequences of initiating an ARV regimen including LPV/r or EFV, using data from a recent clinical trial in a previously published model of HIV-disease.from Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK.

Source: Journal of the International AIDS Society

DOI: 10.1186/1758-2652-11-s1-p312

Authors: KN Simpson, R Rajagopalan, B Dietz, K Garren, S Riddler, R Haubrich

Institutions: Medical University of South Carolina, Abbott (United States), Abbott (Germany), University of Pittsburgh, University of California San Diego

Language: English

Subfield: Emergency Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,600

OpenAlex ID: W2020477306

Cites:

Cited by: 1

Related to: 10